Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,027,201,493.43
- March 10, 2025
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 25, 2020 | CEO | 10,550 | $233.46 | Sell | $2,463,003.00 | |
| Feb. 18, 2020 | CMO | 1,183 | $243.51 | Sell | $288,072.33 | |
| Feb. 18, 2020 | EVP | 3,489 | $243.56 | Sell | $849,780.84 | |
| Feb. 18, 2020 | SVP | 1,279 | $243.62 | Sell | $311,589.98 | |
| Feb. 18, 2020 | CEO | 11,685 | $243.52 | Sell | $2,845,531.20 | |
| Feb. 7, 2020 | Director | 2,000 | $237.82 | Sell | $475,640.00 | |
| Feb. 4, 2020 | Director | 2,000 | $238.84 | Sell | $477,680.00 | |
| Jan. 22, 2020 | EVP | 1 | $237.50 | Sell | $237.50 | |
| Jan. 16, 2020 | EVP | 5,000 | $235.00 | Sell | $1,175,000.00 | |
| Jan. 13, 2020 | SVP | 860 | $229.38 | Sell | $197,266.80 | |
| Jan. 13, 2020 | EVP | 2,125 | $226.78 | Sell | $481,907.50 | |
| Jan. 8, 2020 | EVP | 5,000 | $230.00 | Sell | $1,150,000.00 | |
| Jan. 8, 2020 | SVP | 13,750 | $231.89 | Sell | $3,188,487.50 | |
| Jan. 6, 2020 | EVP | 4,250 | $222.00 | Sell | $943,500.00 | |
| Jan. 2, 2020 | SVP | 25,630 | $218.92 | Sell | $5,610,919.60 | |
| Jan. 2, 2020 | Director | 20,000 | $218.93 | Sell | $4,378,600.00 | |
| Dec. 9, 2019 | EVP | 5,000 | $225.00 | Sell | $1,125,000.00 | |
| Nov. 25, 2019 | EVP | 5,000 | $220.00 | Sell | $1,100,000.00 | |
| Nov. 25, 2019 | CMO | 4,692 | $219.37 | Sell | $1,029,284.04 | |
| Nov. 19, 2019 | EVP | 5,000 | $215.00 | Sell | $1,075,000.00 | |
| Nov. 18, 2019 | CEO | 9,434 | $216.75 | Sell | $2,044,819.50 | |
| Nov. 13, 2019 | EVP | 4,892 | $205.50 | Sell | $1,005,306.00 | |
| Nov. 13, 2019 | SVP | 2,853 | $205.59 | Sell | $586,548.27 | |
| Nov. 8, 2019 | CMO | 509 | $199.00 | Sell | $101,291.00 | |
| Nov. 6, 2019 | EVP | 1,223 | $197.21 | Sell | $241,187.83 | |
| Nov. 4, 2019 | EVP | 4,097 | $200.34 | Sell | $820,792.98 | |
| Nov. 1, 2019 | CEO | 96,822 | $200.02 | Sell | $19,366,336.44 | |
| Nov. 1, 2019 | Director | 1,291 | $200.00 | Sell | $258,200.00 | |
| Oct. 30, 2019 | CMO | 3,057 | $199.00 | Sell | $608,343.00 | |
| Oct. 25, 2019 | EVP | 4,311 | $197.89 | Sell | $853,103.79 | |
| Oct. 22, 2019 | EVP | 3,883 | $190.27 | Sell | $738,818.41 | |
| Oct. 22, 2019 | CMO | 638 | $189.00 | Sell | $120,582.00 | |
| Oct. 22, 2019 | Director | 20,000 | $190.00 | Sell | $3,800,000.00 | |
| Oct. 22, 2019 | CEO | 107,831 | $190.00 | Sell | $20,487,890.00 | |
| Oct. 17, 2019 | EVP | 4,250 | $177.80 | Sell | $755,650.00 | |
| Oct. 14, 2019 | EVP | 2,125 | $174.06 | Sell | $369,877.50 | |
| Oct. 2, 2019 | Director | 8,379 | $166.80 | Sell | $1,397,617.20 | |
| Oct. 1, 2019 | SVP | 188 | $169.11 | Sell | $31,792.68 | |
| Aug. 19, 2019 | EVP | 12,501 | $186.38 | Sell | $2,329,936.38 | |
| Aug. 13, 2019 | Director | 10,000 | $185.00 | Sell | $1,850,000.00 | |
| Aug. 8, 2019 | EVP | 2,125 | $181.89 | Sell | $386,516.25 | |
| Aug. 5, 2019 | EVP | 2,330 | $175.28 | Sell | $408,402.40 | |
| Aug. 2, 2019 | EVP | 2,155 | $177.78 | Sell | $383,115.90 | |
| July 12, 2019 | EVP | 2,125 | $175.27 | Sell | $372,448.75 | |
| July 5, 2019 | EVP | 4,250 | $179.11 | Sell | $761,217.50 | |
| June 19, 2019 | EVP | 2,125 | $181.89 | Sell | $386,516.25 | |
| June 18, 2019 | CEO | 56,030 | $175.39 | Sell | $9,827,101.70 | |
| June 3, 2019 | Director | 720 | $167.08 | Sell | $120,297.60 | |
| May 24, 2019 | CEO | 113,432 | $175.10 | Sell | $19,861,943.20 | |
| May 15, 2019 | EVP | 61 | $165.41 | Sell | $10,090.01 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ourania Tatsis, Ian F Smith, Bastiano Sanna, Bruce I Sachs, Joshua Boger, Peter Mueller, Charles F Wagner Jr, Carmen Bozic, Margaret G Mcglynn, Bruce Sachs, Elaine Ullian, Stuart A. Arbuckle, Kristen Ambrose, Jeffrey Leiden, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Wayne Joseph Riley, Paul Silva, Thomas Graney, Christiana Stamoulis, Kenneth Horton, Sangeeta N. Bhatia, Ian F. Smith, Paul M. Silva, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, William D Young, Jonathan Biller, Edward Morrow Atkinson III, and Lloyd Carney
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 10, 2025.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.